Why the study?
Endothelial dysfunction is an early event in atherogenesis and cardiovascular disease, but its prevalence, determinants, and degree in ART-treated PLWH in northwestern Nigeria required assessment.
Does HIV infection reduce endothelial function in adults?
Cross-Sectional (n=400)
No
Does HIV infection reduce endothelial function in adults?
Mean Difference: -2.83 (95% CI -4.44–-1.21)
Absolute Event Rate: 9.82% vs 12.09%
p-value: p=0.001
ART-treated adults living with HIV exhibit significantly reduced endothelial function compared to HIV-negative controls, driven by HIV status, lower eGFR, and higher LDL cholesterol.
Background: Endothelial dysfunction constitutes an early pathophysiological event in atherogenesis and cardiovascular disease. This study aimed to assess the prevalence, determinants, and degree of endothelial dysfunction in antiretroviral therapy (ART)–treated people living with HIV (PLWH) in northwestern Nigeria using brachial flow-mediated dilatation (FMD). Methods: This was a comparative, cross-sectional study. A total of 200 ART-treated adults living with HIV with no evidence of kidney disease were compared with 200 HIV-negative participants attending a tertiary hospital in Kano, Nigeria, between September 2020 and May 2021. Endothelial function was evaluated by measuring FMD with a high-resolution vascular ultrasound transducer. FMD was calculated as the ratio of the brachial artery diameter after reactive hyperemia to baseline diameter and expressed as a percentage of change. Blood and urine samples were obtained from participants in both arms. Urine albumin-to-creatinine ratio (uACR) was calculated using the 2021 CKD-EPI estimated glomerular filtration rate (eGFR) creatinine-cystatin C equation without the race variable, and low-density lipoprotein (LDL) cholesterol was measured using enzymatic method. Results: The overall mean age (± standard deviation) of the study participants was 42 ± 11 years. Participants in the comparison arm were younger than PLWH (38 ± 11 versus 46 ± 10 years, respectively). The median (interquartile range) uACR was 41.6 (23.2–162.9) mg/g for the ART-treated PLWH versus 14.5 (7.4–27.0) mg/g for healthy controls. PLWH had a significantly lower mean percent FMD when compared to HIV-negative participants (9.8% ± 5.4 versus 12.1% ± 9.2, respectively). Reduced FMD was independently associated with HIV infection (β = –2.83%, 95% CI, –4.44% to –1.21%, p = 0.001), estimated glomerular filtration rate (β = –0.04%, 95% CI, –0.07% to –0.01%, p = 0.004) and LDL cholesterol (β = –1.12%, 95% CI, –2.13% to –0.11%, p = 0.029). Conclusion: HIV-positive status, lower estimated GFR, and higher LDL cholesterol levels were independently associated with endothelial dysfunction. Future prospective studies with larger cohorts of persons living with HIV (and age- and sex-matched HIV-negative controls) are needed to gain further insight into these important findings. In the interim, aggressive management of modifiable risk factors is warranted.
No takes yet. Share an insight, caveat, or question.
Nalado et al. (2023) conducted a cross-sectional in HIV (n=400). HIV infection vs. HIV-negative controls was evaluated on Brachial flow-mediated dilatation (FMD) (β = -2.83%, 95% CI -4.44 to -1.21, p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: